FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.6053
+0.0003 (0.05%)
At close: Jul 8, 2025, 4:00 PM
0.6127
+0.0074 (1.22%)
After-hours: Jul 8, 2025, 7:51 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $23.75 million as of July 8, 2025. Its market cap has decreased by -88.29% in one year.
Market Cap
23.75M
Enterprise Value
22.20M
1-Year Change
-88.29%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $23.75M, a decrease of -97.49%. That is a compound annual growth rate of -92.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 23.74M | -66.17% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |